Viewing nowCombinationOlmesartan Plus Tablet
Olmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
White Life Sciences Co., Ltd.

MFDS item code 201403866 · Approved 2014.08.20 · Insurance code 625200720
Treatment of essential hypertension not controlled with monotherapy
This medication is used to treat essential hypertension in cases where blood pressure is not adequately controlled by monotherapy with either olmesartan medoxomil or hydrochlorothiazide.
Before administering this medicine, it is recommended that the dose of olmesartan medoxomil or hydrochlorothiazide be adjusted individually. If blood pressure is not adequately controlled with the individual components, administer 1 tablet of this medicine once daily, with or without food. Adjust the dose at intervals of 2~4 weeks, taking the patient's blood pressure response into account. A marked reduction in blood pressure may occur when olmesartan medoxomil is added to, or a patient is switched to this medicine (olmesartan medoxomil/hydrochlorothiazide) from, a high-dose hydrochlorothiazide monotherapy regimen, particularly in patients with volume depletion or hyponatremia. In such cases, reduce the hydrochlorothiazide dose to 12.5mg before adding olmesartan medoxomil. <Elderly patients> In elderly patients, start with the lowest dose and use caution when adjusting the dose, taking renal or cardiac function, comorbidities, and other concomitant medications into consideration. <Patients with renal impairment> This medicine (olmesartan medoxomil/hydrochlorothiazide) is generally administered to patients with mild to moderate renal impairment (creatinine clearance>30mL/min). Do not administer this medicine (olmesartan medoxomil/hydrochlorothiazide) to patients with more severe renal impairment, as loop diuretics are preferable to thiazide diuretics in these patients. <Patients with hepatic impairment> Use of this medicine is not recommended because there is no experience with its use in patients with hepatic impairment.
<Children> The safety and efficacy in children have not been established.
This medication can cause serious harm to the fetus and newborn when taken during pregnancy, particularly in the second and third trimesters, therefore it should be discontinued immediately upon confirmation of pregnancy. Do not use this medication in patients with an allergy to this drug or its components, or those with hypersensitivity to certain diuretics, severe renal or hepatic dysfunction, pregnant or nursing women, and patients with certain genetic disorders. Particular caution is required in patients with decreased blood volume, severe heart failure, impaired renal or hepatic function, specific heart diseases, as well as in the elderly or infants. They should be closely monitored while taking this medication. This drug has blood pressure-lowering effects that may cause dizziness or hypotensive symptoms, so if symptoms occur, patients should lie down and rest immediately and may require fluid therapy if necessary. Additionally, this drug can cause electrolyte imbalances, so potassium, sodium, magnesium, and other levels in the blood should be regularly monitored, and appropriate actions should be taken if abnormalities are detected. This drug can interact with various medications; therefore, inform your healthcare provider if you are taking other medications, especially potassium supplements, lithium, non-steroidal anti-inflammatory drugs, and other antihypertensives. During therapy, if symptoms such as skin rash, difficulty breathing, severe headache, eye pain, acute angle-closure glaucoma symptoms, severe dizziness, or edema occur, consult a physician immediately. Women who are breastfeeding should be aware that this medication can be passed into breast milk, which may carry a risk of adverse reactions in infants; discontinuation of breastfeeding or the drug is recommended. It is advisable not to use this medication in children as the safety and effectiveness have not been sufficiently established. In cases of overdose, symptoms may include hypotension, electrolyte imbalance, and dehydration, so it is essential to visit a medical facility promptly for appropriate treatment. Finally, this medication may increase skin sensitivity to sunlight, so it is important to take care regarding UV protection and to regularly check skin condition.
Nausea, hyperuricemia, dizziness, upper respiratory infection, headache, urinary tract infection, chest pain, back pain, peripheral edema, vertigo, abdominal pain, dyspepsia, gastroenteritis, diarrhea, elevated AST, elevated GGT, elevated ALT, hyperlipidemia, increased creatine phosphokinase, hyperglycemia, arthritis, arthralgia, myalgia, cough, rash, hematuria, facial edema, weakness, angioedema, anaphylactic reaction, vomiting, hair loss, pruritus, urticaria, rhabdomyolysis, acute renal failure, increased serum creatinine, palpitations, abdominal pain, chronic malabsorption syndrome, intestinal vascular edema, hyperkalemia, increased blood pressure, epistaxis, asthma, hypokalemia, hyponatremia, hypomagnesemia, hypochloremic alkalosis, hypercalcemia, anorexia, polydipsia, abdominal discomfort, constipation, abdominal cramps, pancreatitis, jaundice, interstitial pneumonia, pulmonary edema, acute respiratory distress syndrome, orthostatic hypotension, arrhythmia, temporary blurred vision, jaundice, choroidal effusion, hepatitis, acute cholecystitis, necrotizing vasculitis, interstitial pneumonia, dyspnea, facial flushing, photosensitivity, autoimmune hepatitis, malaise, nasal obstruction, erectile dysfunction, exacerbation of systemic lupus erythematosus, parathyroid disorder, muscle spasms, paresthesia, weakness, Stevens-Johnson syndrome, erythema multiforme, exfoliative dermatitis, toxic epidermal necrolysis, palpitations, hematuria, hypercholesterolemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, sinusitis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture and should be stored in a tightly closed container. The recommended storage temperature is in a cool place between 1 to 25 degrees Celsius, away from direct sunlight.
Round film-coated tablet with a reddish-yellow color
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
White Life Sciences Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Olmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Prescription medication · Combination
Kookje Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.